NCT01874483View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo

placebo

DRUG

BI 187004

BI 187004, dose 2

DRUG

BI 187004

BI 187004, dose 4

DRUG

BI 187004

BI 187004, dose 5

DRUG

BI 187004

BI 187004, dose 6

DRUG

BI 187004

BI 187004, dose 7

DRUG

BI 187004

BI 187004, dose 1

DRUG

BI 187004

BI 187004, dose 3

Trial Locations (1)

Unknown

1307.2.1 Boehringer Ingelheim Investigational Site, Neuss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY